Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China

Emerg Microbes Infect. 2023 Dec;12(1):2191738. doi: 10.1080/22221751.2023.2191738.

Authors

Liwei Zheng¹, Shuying Liu², Fengmin Lu^{1

3}

Affiliations

¹ Department of Microbiology & Infectious Disease Center, School of Basic Medicine, Peking University Health Science Center, Beijing, People's Republic of China.
² SL Consulting, Thousand Oaks, CA, USA.
³ Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Peking University Hepatology Institute, Beijing, People's Republic of China.

No abstract available

MeSH terms

COVID-19* / epidemiology
China / epidemiology
Humans

Grants and funding

This work was supported by National Natural Science Foundation of China [Grant Number 8214100646].